Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Continuation vs Switch in Advanced RCC
NCT00352859Phase 4Terminated
- Sponsor
- Bayer
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sorafenib in renal cell carcinoma (RCC), sponsored by Bayer. Started Aug 2006; status: terminated.
02
Drugs
sorafenib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00352859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352859.